CBD Oil for Atopic Dermatitis: What Dermatology Says

Atopic dermatitis (AD) affects 15–30% of children and 2–10% of adults in Western countries — it is one of the most common skin diseases, causing suffering proportionate to its prevalence. Chronic itching, dryness, skin cracking, episodes of flare-ups, and limitations in daily life are the everyday reality for patients with AD. More and more people are seeking to complement conventional treatment with CBD. What does dermatology say, and what do studies actually confirm?

KEY INFORMATION
• Casares et al. (Antioxidants, 2020) — a pilot study of CBD cream (0.1%) for AD: significant reduction in TEWL (transepidermal water loss), itching, and EASI score after 8 weeks of use.
• CBD in the skin acts through CB2 receptors (inflammation), TRPV1 (itching and pain), TRPA1 (neurogenic itching), and regulation of sebum production (sebaceous glands).
• The endocannabinoid system in the skin is a key regulator of skin homeostasis — dysregulation of the ECS is associated with the pathophysiology of AD.
• CBD as a topical (cream/ointment) has a significantly better safety profile for AD than oral CBD — minimal systemic absorption.
• CBD complements, but does not replace, conventional AD treatment (corticosteroids, calcineurin inhibitors).

The Endocannabinoid System in the Skin: Why Might CBD Work for AD?

The skin has its own complete endocannabinoid system — CB1 and CB2 receptors are expressed in keratinocytes (epidermal cells), mast cells, T lymphocytes, sebaceous glands, and nerve endings. The ECS in the skin regulates a range of processes crucial for skin homeostasis: proliferation and differentiation of keratinocytes, sebum synthesis, immune and inflammatory response, pain and itch perception, and the integrity of the skin barrier.

In AD, dysregulation of the skin's endocannabinoid system is observed — altered expression of CB2 receptors in inflammatory infiltrates, elevated levels of endogenous cannabinoids in the skin with inflammatory lesions, and disturbances in TRPV1 signaling pathways (a receptor involved in itching and pain). These observations suggest that the ECS is actively involved in the pathophysiology of AD — which in turn justifies the interest in external cannabinoids like CBD as modulators of these disorders.

CBD in the skin acts through: CB2 receptors (reducing inflammation in immune cells, decreasing mast cell and lymphocyte infiltration), TRPV1 (reducing itch and pain signals from nerve endings), TRPA1 (neurogenic itch receptor — key in neuropathic itch associated with AD), and regulation of lipid production by sebaceous glands (which affects the composition of the skin's hydrolipid barrier).

What Do Clinical Studies Say About CBD and AD?

Clinical data on CBD and AD are still limited in quantity but promising in quality. A key study in this field is the work Casares et al. (Antioxidants, 2020) — a pilot, open-label clinical study involving 20 patients with mild to moderate AD.

Study protocol: cream with 0.1% CBD used twice daily for 8 weeks. Evaluated parameters: TEWL (transepidermal water loss — a marker of skin barrier damage), EASI score (Eczema Area and Severity Index — severity scale for AD), VAS itch (visual analog scale for itch). Results after 8 weeks: significant reduction in TEWL (improvement of skin barrier), reduction in EASI score, reduction in VAS itch. Safety profile: no serious side effects.

Study limitations: small sample size (n=20), lack of a placebo control group, open-label nature of the study (no blind trial). This means that the results are very promising but cannot be treated as conclusive evidence — larger randomized studies are necessary. Nevertheless, the study provides the first clinical data confirming the biological rationale for using CBD in AD.

Itching in AD: How Can CBD Reduce It?

Świąd (pruritus) jest najbardziej uciążliwym objawem AZS — przewlekły, intensywny świąd zaburza sen, koncentrację i jakość życia, tworząc błędne koło „świąd → drapanie → zaostrzenie stanu zapalnego → większy świąd”. Redukcja świądu jest jednym z priorytetów leczenia AZS.

CBD may reduce itching through several mechanisms. Through TRPV1 (antagonism): the TRPV1 receptor is activated by inflammatory mediators (histamine, serotonin, bradykinin) that are released in AD. TRPV1 antagonism by CBD blocks the transmission of itch signals to the spinal cord. Through TRPA1 (modulation): the TRPA1 receptor is key in neurogenic and allergic itching — CBD modifies its activity. Through CB2 (reducing inflammation): fewer inflammatory mediators = fewer stimuli activating itch receptors. Through regulation of keratinocytes: CBD may reduce the secretion of pro-inflammatory cytokines by keratinocytes (IL-6, IL-1β), which drive both inflammation and itching.

W badaniu Casares et al. (2020) redukcja świądu mierzonego skalą VAS była jednym z najbardziej wyraźnych efektów leczenia kremem CBD. To jest klinicznie relewantne dla pacjentów z AZS — nawet jeśli CBD nie „wyleczy” AZS, redukcja intensywności świądu może znacząco poprawić jakość życia i przerwać błędne koło drapanek.

Skin Barrier and CBD: How Does TEWL Relate to AD?

A damaged skin barrier is a fundamental problem in AD — and one of the parameters improved in the study by Casares et al. (2020). TEWL (transepidermal water loss) is the amount of water penetrating through the epidermis into the environment — an indicator of skin barrier integrity. In AD, TEWL is elevated, meaning that the skin loses excessive water, becomes dry, and is susceptible to the penetration of allergens and microorganisms.

CBD may support the skin barrier through several mechanisms: regulating ceramide synthesis (key lipids of the epidermal barrier) by influencing lipid metabolism pathways in keratinocytes, reducing inflammation that damages the structure of the epidermis, and regulating sebum by sebaceous glands (excessive or insufficient sebum secretion disrupts the composition of the hydrolipid barrier). Therefore, the improvement in TEWL with the use of CBD cream is mechanistically justified — and clinically confirmed by Casares et al.

Important context: improving TEWL requires regular use of CBD cream for at least 4–8 weeks. The skin barrier is a structure that rebuilds slowly — results should not be expected after a single or a few days of use. In AD, any external therapy requires patience and consistency, which also applies to CBD.

How to use CBD for atopic dermatitis? Practical tips

Optimal use of CBD for atopic dermatitis combines topical forms (for the skin) with possible oral CBD as a systemic supplement.

Topical CBD (cream/ointment): Apply twice daily (morning and evening) to areas with inflammation and itching. The study by Casares et al. used 0.1% CBD — look for products with similar or higher concentrations. Before the first application, conduct a tolerance test: apply a small amount to the inner side of the forearm and observe for 24 hours. With atopic dermatitis, the skin is often hypersensitive — new substances may cause irritation. Choose creams based on ceramides or squalane without irritating artificial fragrances and preservatives.

Oral CBD as a supplement: 15–25 mg of CBD in the morning for systemic effects (reduction of inflammation, modulation of the HPA axis). Flare-ups of atopic dermatitis are often triggered by stress — anxiolytic CBD may reduce the frequency of flare-ups by alleviating stress. In the evening, 25 mg of CBD to support sleep (sleep disturbances are common with intense nighttime itching in atopic dermatitis). Remember that emollients (moisturizing creams without active substances) should be used regularly every 8–12 hours, regardless of CBD — they are the foundation of atopic skin care, which CBD does not replace.

Our observations: Pacjenci z AZS stosujący CBD topical opisują najczęściej poprawę w zakresie świądu i „komfortu skóry” wcześniej niż poprawę widocznych zmian skórnych. Redukcja intensywności nocnego świądu — co poprawia sen — jest często pierwszym zauważanym efektem. Poprawa wyglądu skóry (mniej czerwonych placek, mniejsza łuszczenie) przychodzi wolniej, zazwyczaj po 4–6 tygodniach regularnego stosowania.

Atopic dermatitis in children and CBD: separate safety issues

Atopic dermatitis is the most common dermatological disease in childhood — it affects 15–30% of children, most often starting in the first 2 years of life. Parents of affected children naturally seek milder alternatives to corticosteroids, especially with chronic use. Is CBD an option for children with atopic dermatitis?

Topical CBD (applied to the skin) potentially carries a lower risk for children than oral CBD due to minimal systemic absorption. However, a child's skin is thinner and more permeable than an adult's skin — absorption through the skin may be higher than in adults. Before using topical CBD on a child with atopic dermatitis, it is essential to consult a pediatrician or pediatric dermatologist — there is a lack of clinical data from randomized studies in children with atopic dermatitis.

Oral CBD in children with atopic dermatitis — even greater caution. There is a lack of clinical data on the safety of oral CBD in children with atopic dermatitis. The only data on CBD in children pertains to drug-resistant epilepsy (Epidiolex — a CBD-containing medication) and cannot be directly extrapolated to supplemental use in atopic dermatitis. Do not administer oral CBD to children with atopic dermatitis without clear medical consultation and indication.

The only hemp product safe for children without special precautions is hulled hemp seeds — no cannabinoids, rich nutritional profile (omega-3, protein). As a dietary component, they support overall skin condition through omega-3 fatty acids (EPA/DHA reduce systemic inflammation) and carry no risks associated with the ECS.

Skin microbiome and CBD: a new direction in research

The skin microbiome — a community of microorganisms residing on the skin surface — plays a key role in the pathophysiology of atopic dermatitis. Patients with atopic dermatitis exhibit disproportionately high colonization of Staphylococcus aureus (golden staph) on affected skin areas. S. aureus produces toxins that exacerbate inflammation and itching, creating a vicious cycle: inflammation → barrier damage → S. aureus colonization → more inflammation.

CBD shows antibacterial properties against S. aureus in vitro — particularly against MRSA (methicillin-resistant strains). Data from in vitro studies cannot be directly transferred to clinical efficacy in atopic dermatitis, but suggest that topical CBD may have an additional mechanism of action by limiting staphylococcal colonization. This remains speculative — there are no clinical studies evaluating the impact of CBD on the skin microbiome in patients with atopic dermatitis.

Stress as a triggering factor for atopic dermatitis operates partially through immunosuppression and changes in the skin microbiome composition — elevated cortisol promotes S. aureus colonization. CBD as a stress-reducing agent may indirectly influence the skin microbiome by reducing cortisol. This is another biologically plausible mechanism through which CBD may help with atopic dermatitis — however, like with the gut microbiome, clinical data is preliminary.

CBD and other therapies for atopic dermatitis: when is it worth reaching for cannabidiol?

Atopic dermatitis is a condition with a well-structured treatment approach at various levels of evidence. CBD should be placed appropriately within this therapeutic hierarchy.

First line (strongly recommended by dermatologists): Emollients (the foundation of atopic dermatitis treatment — regular, daily moisturizing), topical corticosteroids during flare-ups (hydrocortisone, mometasone, betamethasone), calcineurin inhibitors (tacrolimus, pimecrolimus) — especially in sensitive locations. CBD does not compete with these therapies — it is considered as a supplement, particularly during remission periods or with mild cases.

Why the interest in CBD for atopic dermatitis: Kortykosteroidy miejscowe, przy długotrwałym stosowaniu, powodują ścieńczenie skóry i inne efekty uboczne. Pacjenci i rodzice dzieci z AZS szukają alternatyw na „łagodniejsze” okresy choroby lub na uzupełnienie emolientów. CBD jako substancja bez ryzyka ścieńczenia skóry i bez steroidogennych efektów ubocznych jest naturalnym kandydatem do tego miejsca.

When CBD is NOT enough: In severe flare-ups of atopic dermatitis with extensive lesions, intense itching, and risk of skin infections — CBD does not have sufficient potency. In such situations, dermatological consultation and the use of medications with proven efficacy are essential. New biologics (dupilumab — IL-4/IL-13 inhibitor) and small molecule JAK inhibitors (baricitinib) are changing the treatment of severe atopic dermatitis. CBD is not a substitute for these therapies in severe cases. More about CBD and skin (acne) can be found in the article CBD for acne.

Frequently asked questions

Does CBD help with atopic dermatitis?

Pilot study Casares et al. (Antioxidants, 2020) showed that CBD cream (0.1%) used for 8 weeks significantly reduced TEWL, itching (VAS), and the severity of atopic dermatitis (EASI). CBD has biologically plausible mechanisms of action in atopic dermatitis through CB2, TRPV1, and TRPA1. The data is promising, but preliminary — larger RCTs are needed.

How to use CBD for atopic dermatitis?

Topical CBD (cream with at least 0.1% CBD) — twice daily on affected areas. Perform a tolerance test on the forearm before application. Oral CBD (15–25 mg/day) as a supplement for systemic effects. Use regularly for a minimum of 4–8 weeks — the skin barrier rebuilds slowly.

Is CBD safe for atopic dermatitis?

Topical CBD — very good safety profile, minimal systemic absorption. Possible contact irritation with hypersensitivity to base ingredients. Oral CBD — safe for adults at typical doses. Before use in children with atopic dermatitis — consult a dermatologist or pediatrician.

Can CBD replace corticosteroids in atopic dermatitis?

No — topical corticosteroids have a significantly stronger effect during atopic dermatitis flare-ups. CBD is a complement, not a substitute. The most justified use of CBD in atopic dermatitis is: maintaining remission, reducing itching in mild cases, supporting the skin barrier between flare-ups. Severe flare-ups require dermatological consultation.

Which CBD is best for atopic dermatitis?

For atopic dermatitis, prefer topical CBD (cream/ointment) with at least 0.1% CBD, based on ceramides, without perfumes and irritating preservatives. Verify the COA for CBD concentration and absence of contaminants. Oral CBD oil 5–10% as a systemic supplement. Always perform a tolerance test before full use.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult with a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04